World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
45905
World Ranking
6987
National Ranking
3674

Overview

Edward A. Stadtmauer is affiliated with the University of Pennsylvania in the United States and has made significant contributions to the field of medicine, with a strong focus on hematology, oncology, molecular biology, genetics, and immunology.

Their research covers a range of topics including:

  • Multiple Myeloma Research and Treatments
  • CAR-T cell therapy research
  • Hematopoietic Stem Cell Transplantation
  • Protein Degradation and Inhibitors
  • Acute Myeloid Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Acute Lymphoblastic Leukemia research

Frequent co-authors collaborating with Edward A. Stadtmauer include:

  • Alfred L. Garfall
  • Dan T. Vogl
  • Adam D. Cohen
  • Adam Waxman
  • Sandra P. Susanibar-Adaniya

Their research has been published extensively in notable venues such as:

  • Blood
  • Transplantation and Cellular Therapy
  • Journal of Clinical Oncology
  • Clinical Lymphoma Myeloma & Leukemia
  • Bone Marrow Transplantation

Selected recent papers authored or co-authored by Edward A. Stadtmauer include:

  • "CRISPR-engineered T cells in patients with refractory cancer," 2020, Science
  • "T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy," 2024, Nature Medicine
  • "Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set," 2020, Blood
  • "Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia," 2020, Journal of Clinical Oncology
  • "Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells," 2023, Cell

Best Publications

  • Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

    Paul G. Richardson;Pieter Sonneveld;Michael W. Schuster;David Irwin

  • Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America

    Donna M. Weber;Christine Chen;Ruben Niesvizky;Michael Wang

  • CRISPR-engineered T cells in patients with refractory cancer

    Edward A. Stadtmauer;Joseph A. Fraietta;Megan M. Davis;Adam D. Cohen

  • Lenalidomide after stem-cell transplantation for multiple myeloma

    Philip L. McCarthy;Kouros Owzar;Craig C. Hofmeister;David D. Hurd

  • Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma

    Gerald P. Linette;Edward A. Stadtmauer;Marcela V. Maus;Aaron P. Rapoport

  • Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse

    Eric L. Sievers;Richard A. Larson;Edward A. Stadtmauer;Elihu Estey

  • bcl-2 Gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia

    Motoi Hanada;Domenico Delia;Antonella Aiello;Edward Stadtmauer

  • NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma

    Aaron P Rapoport;Edward A Stadtmauer;Gwendolyn K Binder-Scholl;Olga Goloubeva

  • Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

    Richard I. Fisher;Steven H. Bernstein;Brad S. Kahl;Benjamin Djulbegovic

  • Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

    John F. DiPersio;Edward A. Stadtmauer;Auayporn Nademanee;Ivana N.M. Micallef

  • A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma

    David S. Siegel;Thomas Martin;Michael Wang;Ravi Vij

  • B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma

    Adam D. Cohen;Alfred L. Garfall;Edward A. Stadtmauer;J. Joseph Melenhorst

  • Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells

    Brian J. Cameron;Andrew B. Gerry;Joseph Dukes;Jane V. Harper

  • Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma

    Alfred L. Garfall;Marcela V. Maus;Wei-Ting Hwang;Simon F. Lacey

  • Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial.

    Paul Gerard Richardson;Pieter Sonneveld;Michael Schuster;David Irwin

  • A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490).

    JM Rowe;JW Andersen;JJ Mazza;JM Bennett

  • Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer

    Edward A. Stadtmauer;Anne O'Neill;Lori J. Goldstein;Pamela A. Crilley

  • Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma.

    M A Dimopoulos;C Chen;A Spencer;R Niesvizky

  • Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence

    Richard A. Larson;Eric L. Sievers;Eric L. Sievers;Edward A. Stadtmauer;Bob Löwenberg

  • Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

    John R. Wingard;Shelly L. Carter;Thomas J. Walsh;Joanne Kurtzberg

Frequent Co-Authors

David L. Porter
David L. Porter University of Pennsylvania
Carl H. June
Carl H. June University of Pennsylvania
Bruce L. Levine
Bruce L. Levine University of Pennsylvania
Marcelo C. Pasquini
Marcelo C. Pasquini Medical College of Wisconsin
Sergio Giralt
Sergio Giralt Memorial Sloan Kettering Cancer Center
Hillard M. Lazarus
Hillard M. Lazarus Case Western Reserve University
Paul G. Richardson
Paul G. Richardson Harvard University
Parameswaran Hari
Parameswaran Hari Medical College of Wisconsin
Kenneth C. Anderson
Kenneth C. Anderson Harvard University
Rosemarie Mick
Rosemarie Mick University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens many doors beyond becoming a doctor. For those interested in healthcare management and leadership roles, earning the cheapest online master degree in healthcare administration can be a smart move. These programs focus on developing skills in healthcare policy, finance, and operations, offering flexibility for working professionals.

Nursing professionals seeking advancement can consider dnp online programs cheap. A Doctor of Nursing Practice (DNP) supports clinical expertise and leadership in advanced practice nursing, often leading to higher salaries and top-tier healthcare roles.

Pharmacists or those aiming for pharmacy roles may benefit from accredited online pharmd programs. These programs are ideal for advancing practice while balancing work and study, emphasizing pharmaceutical care, clinical practice, and patient safety.

Finally, tech-savvy students can explore online health information management degree programs. These degrees offer pathways into the growing field of health data, records management, and health informatics.

Together, these related online degree options provide multiple routes to impactful, high-demand careers in healthcare—all with the convenience and affordability of online study.

Best Scientists Citing Edward A. Stadtmauer

Trending Scientists

Recently Published Articles